Continued Level of Significant Insider Selling at Calithera Biosciences (CALA)

Thursday, September 28, 2017 10:15 PM ET

Continued Level of Significant Insider Selling at Calithera Biosciences (CALA)

One insider — Adage Capital Partners GP Llc, 10% Owner — today, disposed of 576,000 shares of Calithera Biosciences having a market value of approximately $9,008,100, as disclosed in a form 4 document filed with the SEC. There have been 3 insiders with buy/sell transactions in the past 90 days prior to this filing. All of these trades have been sales resulting in the disposition of 6,372 company shares. Adding the most recent activity to this 90-day history indicates insider trades have seen net sales of 582,372 shares and have averaged 145,593 shares per transaction over this time period.

Insider buy/sell trading at Calithera Biosciences is greater than the 266 peer company average over the last 90-day period. The Bio Therapeutic Drugs peer group saw 312 buy/sell trades during this period for an average of 1.2 transactions per company. The number of shares per buy/sell trade for Calithera Biosciences insiders was also higher. Within the peer group there were 8,819,983 shares purchased and 19,144,668 shares sold with company insiders disposing of 33,092 shares on average.

The data obtained in composing and writing in this story eliminates all trading activity reported to the SEC that involves awards, options, exercise of derivative securities, company buy-backs, taxes, gifts, shares acquired via inheritance and tenders or exchange offers.

Using proprietary Natural Language Generation (NLG) technology, UpTick evaluates corporate insider filings reported to the SEC and creates real-time news and analysis to report the most significant insider transactions based on transaction type, size and historical trends.

For more information, contact UpTick at info@uptickdata.com. Copyright 2017 UpTick Data Technologies. All rights reserved.

This entry was posted in InsiderNews and tagged , , , , . Bookmark the permalink.